Skip to main content
. 2021 Nov 8;13(11):2238. doi: 10.3390/v13112238

Figure 1.

Figure 1

Figure 1

(a): Map of India depicting distribution of SARS-CoV-2 genomes sequenced from cases (shown in brackets) reported from the States and Union Territories (UTs) during January 2020 to July 2021. Two letter codes are used to label States and UTs. The number following the State/UT labels indicates the number of sequenced genomes. Note: States/UTs and their codes are as follows. Andaman and Nicobar Islands: AN; Andhra Pradesh: AP; Arunachal Pradesh: AR; Assam: AS; Bihar: BR; Chhattisgarh: CG; Chandigarh: CH; Dadra and Nagar Haveli and Daman and Diu: DNHDD; Delhi: DL; Goa: GA; Gujarat: GJ; Himachal Pradesh: HP; Haryana: HR; Jharkhand: JH; Jammu and Kashmir: JK; Karnataka: KA; Kerala: KL; Ladakh: LA; Lakshadweep: LD; Maharashtra: MH; Meghalaya: ML; Manipur: MN; Madhya Pradesh: MP; Mizoram: MZ; Nagaland: NL; Odisha: OD; Punjab: PB; Puducherry: PY; Rajasthan: RJ; Sikkim: SK; Tamil Nadu: TN; Tripura: TR; Telangana: TS; Uttarakhand: UK; Uttar Pradesh: UP; West Bengal: WB. Cases from DNHDD are as of 23 October 2021 and therefore marked with *. (b): Prevalence of WHO designated variants of concern (VoC) and variants of interest (VoI) based on pan-India genome sequencing coverage.